ArticleOncology letters2016

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB.

Feng Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.